Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Carcinoma of the Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01688999
What this trial is testing

Cabozantinib for Advanced Urothelial Cancer

Who this might be right for
Urothelial CarcinomaUrethral NeoplasmsUrinary Bladder Neoplasms+1 more
National Cancer Institute (NCI) 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT05544552
What this trial is testing

Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations

Who this might be right for
Locally Advanced Urothelial CarcinomaMetastatic Urothelial CarcinomaSolid Tumor+11 more
Tyra Biosciences, Inc 310
Not applicableEnded earlyNCT02202044
What this trial is testing

Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection

Who this might be right for
Bladder Carcinoma
University of Colorado, Denver 13
Not applicableLooking for participantsNCT07602010
What this trial is testing

Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging

Who this might be right for
Bladder CancerUrothelial Carcinoma (UC)Muscle Invasive Bladder Cancer (MIBC)+1 more
Oslo University Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00006351
What this trial is testing

SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
European Organisation for Research and Treatment of Cancer - EORTC 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07625527
What this trial is testing

Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNon Muscle Invasive Bladder Cancer
Tianjin Medical University Second Hospital 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07822373
What this trial is testing

Study Evaluating Bladder Preservation With Enfortumab Vedotin Plus Pembrolizumab in Patients With Muscle-Invasive Urothelial Cancer

Who this might be right for
Muscle-invasive Bladder Urothelial Carcinoma
University of Utah 25
Not applicableStudy completedNCT05946369
What this trial is testing

Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer

Who this might be right for
Urinary Bladder CancerUrinary Bladder NeoplasmBCG+2 more
Ain Shams University 96
Testing effectiveness (Phase 2)Ended earlyNCT02612194
What this trial is testing

LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer

Who this might be right for
Urinary Bladder NeoplasmsUreteral NeoplasmsUrethral Neoplasms
Wake Forest University Health Sciences 8
Testing effectiveness (Phase 2)UnknownNCT03263039
What this trial is testing

Biomarkers in Urothelial Cancer Patients Treated With Pembrolizumab

Who this might be right for
Transitional Cell Carcinoma of the BladderBiomarkers
Erasmus Medical Center 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07332351
What this trial is testing

Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8
University of Washington 33
Not applicableLooking for participantsNCT02379429
What this trial is testing

Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue

Who this might be right for
Bladder CancerUrinary Tract CancerUrothelial Cancer+1 more
National Cancer Institute (NCI) 500
Large-scale testing (Phase 3)Study completedNCT02256436
What this trial is testing

Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)

Who this might be right for
Urothelial Cancer
Merck Sharp & Dohme LLC 542
Large-scale testing (Phase 3)Not Yet RecruitingNCT07346053
What this trial is testing

The Impact of Time-of-day Administration of EV/P on Objective Response Rate in Adults With Advanced Bladder Cancer

Who this might be right for
Advanced Bladder Cancer
Guliz Ozgun 224
Not applicableWithdrawnNCT01060319
What this trial is testing

A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies

Who this might be right for
Bladder CancerSkin CancersBladder (Urothelial, Transitional Cell) Cancer+1 more
Stanford University
Testing effectiveness (Phase 2)Ended earlyNCT02122172
What this trial is testing

Afatinib in Advanced Refractory Urothelial Cancer

Who this might be right for
Distal Urethral CancerProximal Urethral CancerRecurrent Bladder Cancer+6 more
University of Chicago 32
Large-scale testing (Phase 3)Study completedNCT00003701
What this trial is testing

Combination Chemotherapy in Treating Patients With Bladder Cancer

Who this might be right for
Bladder CancerUrethral Cancer
Eastern Cooperative Oncology Group 490
Testing effectiveness (Phase 2)Ended earlyNCT05563272
What this trial is testing

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Who this might be right for
Cervical CancerColorectal CancerEsophageal Cancer+16 more
Telix Pharmaceuticals (Innovations) Pty Ltd 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT00756639
What this trial is testing

Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT00380029
What this trial is testing

Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
UNC Lineberger Comprehensive Cancer Center 27
Next Page